13 Results for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Improved time to quality of life deterioration in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE: The NETTER-1 phase III trialAnnals of oncology, 2017-09, Vol.28 (S5), p.v146-v146 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx368.010Full text available |
| 2 |
Material Type: Article
|
|
Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine TumorsThe New England journal of medicine, 2017-01, Vol.376 (2), p.125 [Peer Reviewed Journal]ISSN: 1533-4406 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1607427Full text available |
| 3 |
Material Type: Article
|
|
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine TumorsThe New England journal of medicine, 2017-01, Vol.376 (2), p.125-135 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1607427 ;PMID: 28076709Full text available |
| 4 |
Material Type: Article
|
|
90Y-DOTA-D-Phe1-Try3- octreotide in therapy of neuroendocrine malignanciesBiopolymers, 2002, Vol.66 (6), p.393-398 [Peer Reviewed Journal]Copyright © 2003 Wiley Periodicals, Inc. ;Copyright 2003 Wiley Periodicals, Inc. ;ISSN: 0006-3525 ;EISSN: 1097-0282 ;DOI: 10.1002/bip.10349 ;PMID: 12658726Full text available |
| 5 |
Material Type: Article
|
|
Netter-1: First Pivotal Phase III Study Evaluating 177Lu-Dotatate in Midgut Neuroendocrine TumoursAnnals of oncology, 2014-09, Vol.25, p.iv405 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu345.34Full text available |
| 6 |
Material Type: Article
|
|
NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysisAnnals of oncology, 2016-10, Vol.27, p.vi137-vi137 [Peer Reviewed Journal]2016 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw369.05Full text available |
| 7 |
Material Type: Article
|
|
O-009 NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatateAnnals of oncology, 2016-06, Vol.27, p.ii121 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw198.09Full text available |
| 8 |
Material Type: Article
|
|
O-009NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatateAnnals of oncology, 2016-06, Vol.27 (suppl_2), p.ii121-ii121 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw198.09Full text available |
| 9 |
Material Type: Article
|
|
Quality of Life Improvements in Patients with progressive Midgut Neuroendocrine Tumors: the NETTER-1 Phase III TrialEuropean journal of nuclear medicine and molecular imaging, 2017, Vol.44, p.S773 [Peer Reviewed Journal]ISSN: 1619-7070 ;ISSN: 1619-7089 ;EISSN: 1619-7089Full text available |
| 10 |
Material Type: Article
|
|
NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatateAnnals of oncology, 2016, Vol.27, p.121 [Peer Reviewed Journal]ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041Full text available |
| 11 |
Material Type: Article
|
|
NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysisAnnals of oncology, 2016, Vol.27 (6) [Peer Reviewed Journal]ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw369.5Full text available |
| 12 |
Material Type: Article
|
|
NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety ResultsEuropean journal of nuclear medicine and molecular imaging, 2016, Vol.43, p.S121 [Peer Reviewed Journal]ISSN: 1619-7070 ;ISSN: 1619-7089 ;EISSN: 1619-7089Full text available |
| 13 |
Material Type: Article
|
|
1165TiPNETTER-1: FIRST PIVOTAL PHASE III STUDY EVALUATING 177LU-DOTATATE IN MIDGUT NEUROENDOCRINE TUMOURSAnnals of oncology, 2014-09, Vol.25 (suppl_4), p.iv405-iv405 [Peer Reviewed Journal]European Society for Medical Oncology 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2014 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu345.34Full text available |
Personalize your results
Refine Search Results
Expand My Results
Subject
- Neuroendocrine Tumors (2)
- Cancer (1)
- Lu-177-Dotatate (1)
- Lymphopenia (1)
- Life Sciences & Biomedicine (1)
- Midgut (1)
- Clinical Trials (1)
- 90y-Dota-D-Phe1-Try3-Octreotide (1)
- Intravenous Administration (1)
- Metastases (1)
- Myelosuppression (1)
- Neuroendocrine Tumors - Drug Therapy (1)
- General & Internal Medicine (1)
- Net (1)
- Cancer Therapies (1)
- Medicine, General & Internal (1)
- Humans (1)
- General Medicine (1)
- Metastasis (1)
- 90y–dota–d‐phe1–try3–octreotide (1)
-
More options
Databases
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||